Familiar names such as Netflix, Facebook and Tesla Motors, along with a number of biotechnology and cloud-computing stocks, have been pummeled in the last month. Facebook Inc (FB.O), for example, has fallen nearly 22 percent from an intraday record reached less than a month ago. Among biotech names, Alexion Pharmaceuticals (ALXN) has declined 23 percent from a February 25 intraday high, and yet the stock on Friday was still up 7 percent for the year. Facebook still traded on Friday at a price-to-sales ratio of nearly 20, making it the most expensive in the S&P 500, which has an overall price-to-sales ratio of 1.7.
via Business News - Yahoo Finance http://ift.tt/1gXInKW
0 commentaires:
Enregistrer un commentaire